Andrea Hunt Net Worth

Andrea Hunt biography

Andrea Hunt serves as Independent Director of the Company. Ms. Hunt served as the Vice President of New Product Gene Therapy, Neuroscience, Oncology and Ophthalmology with Shire from June 2016 until June 2017, where she developed and integrated disease area strategies for Shire’s gene therapy platform, Neuroscience, Oncology and Ophthalmology franchises. She previously served as the Vice President - Global Franchise Head for Blood Disorders with Baxalta from June 2015 to June 2016 before it was acquired by Shire. From 1988 to 2015, Ms. Hunt served in various roles with Baxter Healthcare, most recently as Vice President - Lead BAX855 and Gene Therapy in the Biosciences division from 2014 to June 2015. Ms. Hunt serves on the board of OX2 Therapeutics, Ryan Banks Academy and is an advisor to Cell One Partners. She previously served as a board member of the Alliance for

What is the salary of Andrea Hunt?

As the Independent Director of Catalyst Biosciences Inc, the total compensation of Andrea Hunt at Catalyst Biosciences Inc is $81,130. There are 6 executives at Catalyst Biosciences Inc getting paid more, with Nassim Usman having the highest compensation of $1,198,860.

How old is Andrea Hunt?

Andrea Hunt is 60, she's been the Independent Director of Catalyst Biosciences Inc since 2017. There are 7 older and 1 younger executives at Catalyst Biosciences Inc. The oldest executive at Catalyst Biosciences Inc is Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D., 67, who is the Consultant.

What's Andrea Hunt's mailing address?

Andrea's mailing address filed with the SEC is C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BLVD., SUITE 120, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Catalyst Biosciences Inc

Over the last 9 years, insiders at Catalyst Biosciences Inc have traded over $2,614,728 worth of Catalyst Biosciences Inc stock and bought 81,771 units worth $199,380 . The most active insiders traders include Jeff Himawan, James E Deerfield Mgmt L.P.... y Augustine Lawlor. On average, Catalyst Biosciences Inc executives and independent directors trade stock every 62 days with the average trade being worth of $3,315. The most recent stock trade was executed by Nassim Usman on 9 August 2022, trading 3,250 units of CBIO stock currently worth $1,528.

What does Catalyst Biosciences Inc do?

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

Catalyst Biosciences Inc executives and stock owners

Catalyst Biosciences Inc executives and other stock owners filed with the SEC include:

• Nassim Usman,
  President, Chief Executive Officer, Director
• Dr. Nassim Usman Ph.D.,
  Pres, CEO & Director
• Howard Levy,
  Chief Medical Officer
• Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
  Consultant
• Augustine Lawlor,
  Independent Chairman of the Board
• Errol De Souza,
  Independent Director
• Andrea Hunt,
  Independent Director
• Edward Williams,
  Independent Director
• Ana Kapor,
  IR Contact Officer
• Sharon Tetlow,
  Independent Director
• Geoffrey Ling,
  Independent Director
• Charles Democko,
  Senior Vice President - Regulatory Affairs
• Clinton Musil,
  Chief Financial Officer
• Dr. Tom Knudsen D.V.M., Ph.D.,
  Sr. VP of Corp. Devel.
• Dr. Grant Blouse M.Sc., Ph.D.,
  Chief Scientific Officer
• Seline Miller CPA,
  Sr. VP of Fin., Interim Chief Financial & Principal Accounting Officer
• John P Richard,
  Director
• Stephen A Hill,
  Director
• Edwin Madison,
  Chief Scientific Officer
• Fletcher Payne,
  Chief Financial Officer
• Harold E Selick,
  Director
• Group Ltd.Gni Hong Kong Ltd...,
  
• Seline E. Miller,
  SVP Finance; Interim CFO & PAO
• James E Deerfield Mgmt L.P....,
  
• Eddie Williams,
  Director
• Jeff Himawan,
  Director
• Veronica Cai,
  Controller
• Grant E. Blouse,
  Chief Scientific Officer
• Jeanne Y Jew,
  Director
• Hong Kong Ltd Gni,